Studies gut and mouth bacteria in people suspected of pancreatic cancer
Looks at microbes in swabs from adults suspected of having pancreatic cancer.
Plain-language title generated from the registry record
Registry title: The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
Key facts
- Where
- Herlev, DenmarkSee the site
AI summary: who the study is looking for
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with a suspected lesion in the pancreas who are having an endoscopic procedure. Researchers study the microbiome (germs living in the body) in pancreatic cancer.
- Age
- 18 years or older
- Sex
- All sexes can join
- Disease stage
- A suspected solid or cystic lesion in the pancreas, going to have a diagnostic or therapeutic endoscopic procedure
Main reasons for not taking part
- Cannot have an endoscopic or surgical procedure, for example because of a blood clotting problem that has not been corrected
Read by machine on 9 November 2026.
Where in Denmark
- Herlev og Gentofte HospitalHerlev, DenmarkTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Herlev Hospital
- Trial code
- NCT07250100
- Record updated
- 26 November 2025
- Original description
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response.Read full original descriptionShow less
The Role of Microbiota in Pancreatic Cancer and Precursor Lesions
This is a prospective observational study aiming to investigate the microbiome in patients suspected of having pancreatic cancer. The purpose is to enhance diagnostic accuracy by developing screening protocols for high-risk individuals, identifying specific microbial biomarkers, and improving prognostic criteria to optimize treatment response.
Participants will be asked to complete a questionnaire, provide oral and fecal swabs, and-if clinically indicated-1-2 pancreatic biopsies will be collected.
Inclusion: Patients with a suspected lesion (solid/cystic) in the pancreas undergoing diagnostic or therapeutic endoscopic procedure; Age of 18 years or above; Signed informed consent form.
Exclusion: Contraindications for endoscopic or surgical procedure, such as uncorrected coagulopathy.